SCHEMBL6794897

SCHEMBL6794897

NC(=O)c1ccccc1NC(=O)CCCN1CCC(c2ccccc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.53
HTR1A P08908 3/20 0.53
ALDH1A1 P00352 3/20 0.51
GAA P10253 2/20 0.51
LMNA P02545 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 1/20 0.47
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
DRD2 P14416 1/20 0.47
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HDAC1 Q13547 1/20 0.46
BCHE P06276 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6802419 0.94 HTR7 (0.57) HTR7HTR1AALDH1A1KDM4EDRD2
SCHEMBL6795910 0.90 HTR7 (0.53) HTR7HTR1AALDH1A1KDM4EPRMT5
SCHEMBL6795402 0.86 HTR1A (0.56) HTR7HTR1AALDH1A1KMT2AKDM4E
SCHEMBL6795772 0.83 HTR1A (0.53) HTR7HTR1AALDH1A1KMT2AKDM4E
SCHEMBL9070717 0.80 ADRA1D (0.65) HTR7HTR1AALDH1A1LMNATSHR
SCHEMBL6798006 0.78 HTR1A (0.75) HTR7HTR1AALDH1A1LMNAKMT2A
SCHEMBL12209894 0.78 KMT2A (0.66) HTR7ALDH1A1GAALMNAKMT2A
SCHEMBL6796837 0.78 SIGMAR1 (0.57) HTR7HTR1APRMT5WDR77SIGMAR1
SCHEMBL6796840 0.78 SIGMAR1 (0.57) HTR7HTR1APRMT5WDR77SIGMAR1
SCHEMBL11465879 0.77 CARM1 (0.54) HTR7KMT2ADRD2TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040077667-A1 Quinazolinone derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-04-22 US disclosed
EP-1355888-A1 QUINAZOLINONE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-10-29 EP disclosed
WO-2002048117-A1 QUINAZOLINONE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077667-A1 Quinazolinone derivatives PARP1, PARP9, PARP2 HTR7 1045/4885HTR1A 848/4885ALDH1A1 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.